PMID: 37813Aug 1, 1979

Neurotransmitter receptors in frontal cortex of schizophrenics

Archives of General Psychiatry
J P BennettS H Snyder

Abstract

Frontal cerebral cortex brain samples from schizophrenics and controls have been assayed for binding associated with muscarinic cholinergic, serotonin (5HT), gamma-aminobutyric acid (GABA), and beta-adrenergic receptors as well as for the activity of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). Binding levels of tritium-LSD, presumably associated with postsynaptic 5HT receptors, were reduced 40% to 50% in samples from schizophrenics in three independent studies, whereas no other consistent alteration was observed in levels of binding associated with other receptors or in the activity of GAD. This change in receptor binding levels does not seem to be attributable to postmortem changes, to influence of drugs received by the patients, or to demographic features of the patient populations.

References

Sep 28, 2013·Biochemical Pharmacology·Raymond J WinquistMichael Williams
Dec 2, 1998·Neuropharmacology·J F López-GiménezG Mengod
Nov 28, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Carolina MuguruzaJavier González-Maeso
Jul 27, 2001·Journal of Chemical Neuroanatomy·T M Hyde, J M Crook
Jan 1, 1991·Journal of Neural Transmission. General Section·S MatsubaraH Y Meltzer
Jan 1, 1991·Journal of Neural Transmission. General Section·R C Arora, H Y Meltzer
Jan 1, 1987·Progress in Neuro-psychopharmacology & Biological Psychiatry·D G Morgan
Jan 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·M R Lynch
Jan 21, 2000·Psychiatry Research·N P VerhoeffR B Innis
Mar 1, 1997·Journal of Psychiatric Research·B G BunneyW E Bunney
Mar 1, 1997·Journal of Psychiatric Research·J F Deakin, M D Simpson
Sep 12, 2000·Psychiatry Research·P GovitrapongA Srikiatkhachorn
Jun 1, 1982·Psychiatry Research·H KaiyaS Nakamura
May 1, 1993·Psychiatry Research·R C Arora, H Y Meltzer
Dec 4, 1998·Biological Psychiatry·J A LiebermanJ E Kraus
May 15, 1990·Biological Psychiatry·P A McBrideJ J Mann
Sep 18, 1996·Schizophrenia Research·Brian Dean, W Hayes
Jan 1, 1996·Behavioural Brain Research·Brian DeanD Copolov
Jan 1, 1991·The International Journal of Neuroscience·R Sandyk, S R Kay
Jun 1, 1990·The International Journal of Neuroscience·R Sandyk, R Pardeshi
Dec 24, 2008·Expert Review of Neurotherapeutics·Elizabeth Scarr, Brian Dean
Jul 12, 2011·Expert Opinion on Investigational Drugs·Bjørn H EbdrupBirte Glenthøj
Dec 5, 2015·Frontiers in Psychiatry·Seong-Wook KimSukchan Lee
Oct 30, 2008·Journal of Neurochemistry·Elizabeth Scarr, Brian Dean
Apr 18, 2012·Journal of Cellular and Molecular Medicine·Vincenza Rita Lo VascoPatrizia Polonia
Sep 3, 1999·Biological Psychiatry·J C Soares, R B Innis
Jul 16, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jeffrey K YaoRavinder D Reddy
Jul 1, 1983·Journal of Neurochemistry·R Rodnight
Dec 1, 1984·Journal of Neurochemistry·J O MarcussonB Winblad
Nov 1, 1985·Journal of Neurochemistry·J A SeversonB Winblad
Apr 1, 1987·Journal of the American Geriatrics Society·D G MorganC E Finch
Sep 1, 1984·Journal of Neurochemistry·S TelangS J Enna

Related Concepts

Antipsychotic Effect
Adrenal Cortex Diseases
Schizophrenia
Serotonin Measurement
Quinuclidines
Maple Syrup Urine Disease
Serotonin
Receptors, Tryptamine
Glutamate Decarboxylase
Norepinephrine, (+, -)-Isomer

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.